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Case Report
Right Ventricular Thrombus in a 36-Year-Old Man with 
Factor V Leiden 
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Abstract
Factor V Leiden deficiency is the most common hereditary hypercoagulable disease in the United States and involves 
5% of the Caucasian population. Up to 30% of patients who present with deep vein thrombosis (DVT) or pulmonary 
thromboembolism present with this condition. This is a case report of a 36-year-old man who experienced one episode of 
DVT within the previous year and was admitted to our hospital due to productive coughs and hemoptysis. Paraclinical studies 
demonstrated a right ventricular thrombus. Additional investigation was done to find the underlying cause. Laboratory tests 
were positive for Factor V Leiden mutation. Other factors for hypercoagulability states were normal. Given that Factor 
V Leiden mutation is a life-threatening condition with a relatively high prevalence and considering its thrombogenesis, 
screening tests are necessary in young patients without obvious reasons for recurrent thrombus formation. It seems that 
medical noninvasive treatments can be an alternative therapy to surgery when a ventricular thrombus is suspected in these 
patients.
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Introduction
Cardiac masses are not rare, with their differential 
diagnoses comprising tumors, thrombi, and inflammatory 
causes.1 Ventricular thrombi have been reported in patients 
with the antiphospholipid syndrome2 and other types of 
hypercoagulable states. They can be a complication of 
myocardial infarction and deep vein thrombosis (DVT).3
Factor V Leiden deficiency is the most common hereditary 
hypercoagulable disease in the United States and involves 
5% of the Caucasian population.4 Factor V Leiden leads to 
activated protein C resistance, and it has been demonstrated 
as a risk factor for venous thrombosis development.5 
Approximately one out of 1000 patients will develop DVT 
or pulmonary thromboembolism each year. Heterozygous 
Factor V Leiden increases the risk of developing DVT by 5 
to 7 fold, while homozygous Factor V Leiden increases the 
risk of developing clots by 25 to 50 fold.6
Here, we describe a middle-aged male patient, presenting 
with a cardiac mass as an indicator of the Factor V Leiden 
deficiency syndrome.
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Case Presentation
A 36-year-old male non-smoker was admitted to our clinic 
with intermittent productive coughs and hemoptysis in the 
previous 2 months for further evaluation. He mentioned that 
the coughs had started 7 months previously and that they 
were relieved with Salbutamol spray, leaving him symptom-
free for 2 months. The patient had never complained of chest 
pain or paroxysmal nocturnal dyspnea and orthopnea before. 
However, his condition began to deteriorate after 2 months 
since the previous medication was not effective enough, and 
he referred to a pulmonologist. In his medical history, DVT in 
the left leg was noticeable in about 1.5 years previously, which 
at the time led to his hospital admission for anticoagulant 
therapy. One week afterward, he was discharged on daily 
Warfarin and was arranged to have international normalized 
ratio (INR) follow-up. Unfortunately, due to thyroid 
hemorrhage, he underwent a partial thyroidectomy and 
Levothyroxine was added to his medical treatment and the 
Warfarin dose was decreased. He was under treatment with 
low-dose Warfarin when he referred to our clinic. In social 
history, he only stated occasional alcohol intake. There was 
no history of malignancy, emboli, antiphospholipid antibody 
syndrome, and other types of hypercoagulable states in his 
family. In physical examination, no lymphadenopathy was 
detected and everything else was unremarkable. Primary 
laboratory data revealed normocytic anemia (hemoglobin = 
10.9), with normal serum iron level and total iron-binding 
capacity. Other routine laboratory tests were within normal 
ranges. The pulmonary function test demonstrated small 
airway obstruction with a 19.2% rise in the forced expiratory 
volume in one second (FEV1) after short-acting beta-agonist 
inhalation. Electrocardiography (ECG) showed normal sinus 
rhythm with a normal axis, and there were no ST-T segment 
changes. Chest X-ray illustrated a normal pattern (Figure 1). 
Echocardiography revealed normal left ventricular size with 
good systolic function (ejection fraction = 55%), normal right 
ventricular size and function, no wall motion abnormality, 
and mild tricuspid regurgitation. The pulmonary artery 
pressure was estimated at 35 mmHg. A large (36 × 20 mm), 
echogenic semi-mobile mass was seen in the right ventricle 
attached to the interventricular septum (Figure 2). Thoracic 
spiral multi-slice double-contrast computed tomography 
(CT) demonstrated a filling defect in the right ventricle, 
measuring 35 mm (Figure 3). No pulmonary artery embolism 
was detected in CT angiography. Cardiac magnetic resonance 
imaging (CMR) demonstrated a lobulated mass lesion in 
the right ventricle (38 × 26 mm), with invasion into the 
interventricular septum, suggestive of thrombosis according 
to different sequences. Abnormal enhancement in the right 
lung, most probably due to pulmonary infarction, was 
further depicted. The other parameters ware normal (Figure 
4). Venous Doppler ultrasound of the lower extremities 
showed no evidence of DVT. For the evaluation of anemia, 
upper and lower gastrointestinal endoscopy was done, which 
detected no pathology. Bone marrow aspiration was normal. 
Paroxysmal nocturnal hematuria (characterized by the triad 
of hemolytic anemia, hematuria, and thrombosis) was ruled 
out by the Ham test. The patient was tested for coagulation 
factor activity, and the screening test was positive for Factor 
V Leiden. We decided to treat the patient with medical 
therapy.  Anticoagulant therapy was administrated forthwith 
(Heparin drip and Warfarin). He was discharged with advice 
for Warfarin consumption and follow-up. After a 2-month 
follow-up, there was no sign of any mass in echocardiography 
(Figure 5).
Figure 1. Chest X-ray, showing a normal pattern
Figure 2. Transthoracic echocardiography (right parasternal long-axis 
view), revealing an echogenic mass (arrow) in the right ventricle attached 
to the interventricular septum 
IVS, Interventricular septum; LV, Left ventricle; RV, Right ventricle
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Figure 5. Delayed echocardiography (apical four-chamber view), detecting no 
evidence of the right ventricular mass after two months of Warfarin therapy
LA, Left atrium; LV, Left ventricle; MV, Mitral valve; RA, Right atrium; 
RV, Right ventricle; TV, Tricuspid valve
Discussion
Cardiac masses can produce a variety of symptoms 
consisting of constitutional symptoms (fever, chills, fatigue, 
malaise, myalgia, arthralgia, and muscle weakness), embolic 
phenomena (systemic or pulmonary embolism), and cardiac 
manifestations (arrhythmias, ventricular outflow tract 
obstruction, valvular dysfunction, dyspnea, orthopnea, 
paroxysmal nocturnal dyspnea, cough, hemoptysis, and 
chest pain).7 For distinction between differential diagnoses, 
physical examination coupled with appropriate laboratory 
tests is useful. Nevertheless, echocardiography, chest CT 
scan with contrast, and CMR with contrast are superior 
modalities for the characterization of the lesion.7 Studies 
have found that about 5% of Caucasians in North America 
and up to 30% of patients presenting with DVT or pulmonary 
thromboembolism suffer from Factor V Leiden mutation.8 
Massive pulmonary emboli with bilateral DVT were reported 
in a 49-year-old with Factor V Leiden mutation.9 In a study 
by Sveinsdottir et al.,10 it was concluded that the recurrence of 
venous thromboemboli was strongly associated with Factor 
V Leiden mutation in the heterozygous form. Another study 
suggested screening of Factor V Leiden mutation in patients 
younger than 50 years suspected of hypercoagulability 
states.11 There are, however, other types of hypercoagulability 
states which can present with cardiac masses. Recently, 
Nagae et al.12 reported a right ventricular mass in a 14-year-
old female patient presenting with fever, DVT, and chest 
pain diagnosed with familial Heparin cofactor II deficiency. 
Other cardiac chambers are also reported to be involved 
with similar conditions. Corre et al.13 reported a coronary 
sinus thrombosis due to Factor V Leiden deficiency. As most 
patients with mutant genes will manifest the signs of Factor 
V Leiden deficiency at younger ages, it is suggested that 
any young patient with a cardiac thrombus should be further 
evaluated for coagulation proteins and genes. Moreover, as 
these patients are highly susceptible to thrombus formation, 
it seems that medical therapy can be an alternative to surgery 
when a ventricular thrombus is suspected.
Conclusion 
Thrombosis is one of the most common causes of right 
Figure 3. Chest computed tomography scan, illustrating a filling defect (ar-
row) in the right side of the heart measuring 35 mm
LV, Left ventricle; RV, Right ventricle
Figure 4. Cardiac magnetic resonance imaging, demonstrating a lobulated 
mass lesion (arrow) in the right ventricle
LA, Left atrium; LV, Left ventricle; RA, Right atrium; RV, Right ventricle
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ventricular masses. Given the relatively high prevalence of 
Factor V Leiden mutation and its life-threatening potential, 
screening tests are necessary in young patients without 
obvious reasons for recurrent thrombus formation. It seems 
that medical noninvasive treatments can be an alternative 
therapy to surgery when a ventricular thrombus is suspected 
in these patients.
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